Korean J Ophthalmol.  2006 Jun;20(2):99-103. 10.3341/kjo.2006.20.2.99.

Triamcinolone-Induced Intraocular Pressure Elevation: Intravitreal Injection for Macular Edema and Posterior Subtenon Injection for Uveitis

Affiliations
  • 1Department of Ophthalmology, College of Medicine, Pusan National University, Busan, Korea. jea-sy@hanmail.net

Abstract

PURPOSE: To assess the effect of intravitreal and posterior subtenon injections of triamcinolone acetonide (TA) on intraocular pressure (IOP). METHODS: we reviewed 42 consecutive eyes after intravitreal TA injection (IVTA) and 43 eyes following posterior subtenon TA injection (PSTA). All cases had a minimum follow-up time of three months. After injection, the value and time of the maximal IOP, the amount of IOP elevation and the needs of the medication were assessed. RESULTS: The IOP increased significantly (p<0.001) from 16.3+/-2.5 mmHg preoperatively to a mean maximum of 21.7+/-5.3 mmHg in the IVTA group, and from 15.3+/-4.5 mmHg to 20.6+/-3.0 mmHg in the PSTA group. An elevation in the IOP of more than 5 mmHg from the baseline IOP was seen in 52.4% of the IVTA group at a mean time of 3.1 weeks postoperatively, and 44.2% of the PSTA group displayed an IOP elevation at 5.9 weeks. CONCLUSIONS: Both developed significant elevations of IOP, but this appeared at a later date in the PSTA group. Careful follow-up after local injection of steroids is necessary.

Keyword

Intraocular pressure; Intravitreal injection; Subtenon injection; Triamcinolon acetonide

MeSH Terms

Vitreous Body
Uveitis, Posterior/*drug therapy/pathology
Triamcinolone Acetonide/administration & dosage/*adverse effects
Time Factors
Retrospective Studies
Orbit
Ocular Hypertension/*chemically induced/physiopathology
Middle Aged
Male
Macular Edema, Cystoid/*drug therapy/pathology
Intraocular Pressure/*drug effects
Injections
Humans
Glucocorticoids/administration & dosage/*adverse effects
Follow-Up Studies
Female
Aged, 80 and over
Aged
Adult

Cited by  1 articles

Surgical Removal of Sub-Tenon Triamcinolone Acetonide in Cases of Increased Intraocular Pressure after Sub-Tenon Injection
Sang Won Ha, Myoung Jun Kim, Dong Ho Park, Si Yeol Kim, Jae Pil Shin
J Korean Ophthalmol Soc. 2012;53(1):175-179.    doi: 10.3341/jkos.2012.53.1.175.


Reference

1. Forster DJ, Rao NA, Smith RE. Corticosteroids in the treatment of intermediate uveitis. Dev Ophthalmol. 1992; 23:163–170. PMID: 1730352.
Article
2. McCartney HJ, Drysdale IO, Gornall AG, Basu PK. An autoradiographic study of the penetration of subconjunctivally injected hydrocortisone into normal and inflamed rabbit eyes. Invest Ophthalmol. 1965; 4:297–302. PMID: 14326615.
3. Hyndiuk RA, Reagan MG. Radioactive depot-corticosteroid penetration into monkey ocular tissue. I: Retrobulbar and systemic administration. Arch Ophthalmol. 1968; 80:499–503. PMID: 4970748.
4. Antcliff RJ, Spalton DJ, Stanford MR, graham EM, et al. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology. 2001; 108:765–772. PMID: 11297495.
Article
5. Jonas JB, Hayler JK, Sofker A, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol. 2001; 131:468–471. PMID: 11292410.
Article
6. Danis RP, Ciullar TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-relative macular degeneration. Retina. 2000; 20:244–250. PMID: 10872928.
7. Jonas JB, Hayler JK, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol. 2000; 84:1064–1067. PMID: 10966969.
Article
8. Jonas JB. Intraocular availability of triamcinolone acetonide after intravitreal injection. Am J Ophthalmol. 2004; 137:560–562. PMID: 15013884.
Article
9. Armaly MF. Statistical attributes of the steroid hypertensive response in the clinically normal eye. Invest Ophthalmol. 1965; 4:187–197. PMID: 14283012.
10. Jonas JB, Kreissig I, Degenring R. Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide. Arch Ophthalmol. 2003; 121:729–730. PMID: 12742856.
Article
11. Ritch R, Sheild MB, Krupin T. The glaucomas. 1996. Vol. 2:2nd ed. St. Louis: Mosby;p. 1177–1188.
12. Sophie J, Paul M. The effect of intravitreal Triamcinolone Acetonide on Intraocular Pressure. Ophthalmic Surg Lasers Imaging. 2003; 34:386–390. PMID: 14509462.
Article
13. Scholes GN, O'Brien WJ, Abrams GW. Clearance of triamcinolone from vitreous. Arch Ophthalmol. 1985; 103:1567–1569. PMID: 4051860.
Article
14. Beer PM, Bakri SJ, Singh RJ, et al. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology. 2003; 110:681–686. PMID: 12689886.
Article
15. Agrawal S, Agrawal J, Agrawal PT. Vitrectomy as a treatment for elevated intraocular presure following intravitreal injection of triamcinolone acetonide. Am J Ophthalmol. 2004; 138:679–680. PMID: 15488813.
16. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol. 2003; 87:24–27. PMID: 12488256.
Article
17. Bakri SJ, Beer PM. The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers Imaging. 2003; 34:386–390. PMID: 14509462.
Article
18. Gilles MC, Simpson JM, Billson FA, et al. Safety of an intravitreal injection of triamcinolone:results from a randomized clinical trial. Arch Ophthalmol. 2004; 122:336–340. PMID: 15006845.
19. Yang YH, Kim KR, Yang SW, Yim HB. The Effect of Intravitreal Triamcinolone Acetonide on Intraocular Pressure. J Korean Ophthalmol Soc. 2004; 45:1081–1085.
20. Kalina PH, Erie JC, Rosenbaum L. Biochemical quantification of triamcinolone in subconjunctival depots. Arch Ophthalmol. 1995; 113:867–869. PMID: 7605276.
Article
21. Kalina RE. Increased intraocular pressure following subconjunctival corticosteroid administration. Arch Ophthalmol. 1969; 81:788–790. PMID: 5783749.
Article
22. Herschler J. Increased intraocular pressure induced by repository corticosteroids. Am J Ophthalmol. 1976; 82:90–93. PMID: 937460.
Article
23. Panek WC, Holland GN, Lee DA, Christensen RE. Glaucoma in patients with uveitis. Br J Ophthalmol. 1990; 74:223–227. PMID: 2337547.
Article
24. Kim YJ, Kang SW, Ahn BH, Ham DI. The results of posterior subtenon steroid injection in uveitis patients. J Korean Ophthalmol Soc. 2003; 44:66–72.
Full Text Links
  • KJO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr